CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: July 13, 2007
Result type: Reports
Project Number: S0104
Product Line: Common Drug Review

Generic Name: Idursulfase

Brand Name: Elaprase

Manufacturer: Shire Human Genetic Therapies, Inc.

Indications: Mucopolysaccharidosis II (MPS II), Hunter Syndrome

Submission Type: New

Project Status: Complete

Date Recommendation Issued: December 19, 2007

Recommendation Type: Do not list